Jonathan J. Hodgins

Contribution of NK cells to immunotherapy mediated by PD-1/PD-L1 blockade

Joy Hsu, Jonathan J. Hodgins, Malvika Marathe et al. · Journal of Clinical Investigation · 2018 · 827 citations · Full text

Life Sciences, Immunology, Oncology +17

When killers become thieves: Trogocytosed PD-1 inhibits NK cells in cancer

Mohamed S. Hasim, Marie Marotel, Jonathan J. Hodgins et al. · Science Advances · 2022 · 101 citations · Full text

Life Sciences, Immunology, Oncology +17

Induction of a distinct macrophage population and protection from lung injury and fibrosis by Notch2 blockade

Mayra Cruz Tleugabulova, Sandra P. Melo, Aaron K. Wong et al. · Nature Communications · 2024 · 29 citations · Full text

Life Sciences, Cell Biology, Immunology +17

Loss of the Ste20-like kinase induces a basal/stem-like phenotype in HER2-positive breast cancers

Khalid N. Al‐Zahrani, John Abou‐Hamad, David P. Cook et al. · Oncogene · 2020 · 20 citations

Medicine, Cancer Biology, Oncology +15

CEACAM1 is a direct SOX10 target and inhibits melanoma immune infiltration and stemness

John Abou‐Hamad, Jonathan J. Hodgins, Christiano Tanese de Souza et al. · iScience · 2022 · 20 citations · Full text

Medicine, Cancer Biology, Oncology +17